These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37525583)

  • 1. Garcinolic Acid Distinguishes Between GACKIX Domains and Modulates Interaction Networks.
    Breen ME; Joy ST; Baruti OJ; Beyersdorf MS; Henley MJ; De Salle SN; Ycas PD; Croskey A; Cierpicki T; Pomerantz WCK; Mapp AK
    Chembiochem; 2023 Nov; 24(21):e202300439. PubMed ID: 37525583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
    Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
    J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
    Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
    J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent Chemical Cochaperones of the p300/CBP GACKIX Domain.
    Lodge JM; Majmudar CY; Clayton J; Mapp AK
    Chembiochem; 2018 Sep; 19(18):1907-1912. PubMed ID: 29939485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
    Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
    Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.
    Gee CT; Koleski EJ; Pomerantz WC
    Angew Chem Int Ed Engl; 2015 Mar; 54(12):3735-9. PubMed ID: 25651535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
    Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
    PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
    Cook PR; Polakowski N; Lemasson I
    J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared structural features of the 9aaTAD family in complex with CBP.
    Piskacek M; Vasku A; Hajek R; Knight A
    Mol Biosyst; 2015 Mar; 11(3):844-51. PubMed ID: 25564305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein.
    Shaywitz AJ; Dove SL; Kornhauser JM; Hochschild A; Greenberg ME
    Mol Cell Biol; 2000 Dec; 20(24):9409-22. PubMed ID: 11094091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding mode and transcriptional activation potential of high affinity ligands for the CBP KIX domain.
    Volkman HM; Rutledge SE; Schepartz A
    J Am Chem Soc; 2005 Apr; 127(13):4649-58. PubMed ID: 15796530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting allostery in CREB-binding protein (CBP) using residue-based interaction energy.
    Yazar M; Ozbek P
    J Comput Aided Mol Des; 2020 Sep; 34(9):965-974. PubMed ID: 32430574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
    Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
    Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Labeling of the CBP/p300 KIX Domain for
    Gee CT; Arntson KE; Koleski EJ; Staebell RL; Pomerantz WCK
    Chembiochem; 2018 May; 19(9):963-969. PubMed ID: 29430847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
    Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
    Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300.
    Ramírez JA; Nyborg JK
    J Mol Biol; 2007 Sep; 372(4):958-969. PubMed ID: 17707401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
    Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.
    Geiger TR; Sharma N; Kim YM; Nyborg JK
    Mol Cell Biol; 2008 Feb; 28(4):1383-92. PubMed ID: 18070920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent.
    Georges SA; Giebler HA; Cole PA; Luger K; Laybourn PJ; Nyborg JK
    Mol Cell Biol; 2003 May; 23(10):3392-404. PubMed ID: 12724399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.